M R7 (Rabeprazole sodium delayed-release 20 mg)
Pill with imprint M R7 is Beige, Round and has been identified as Rabeprazole sodium delayed-release 20 mg. It is supplied by Mylan Pharmaceuticals Inc..
Rabeprazole is used in the treatment of gerd; barrett's esophagus; duodenal ulcer; erosive esophagitis; duodenal ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for M R7
More about rabeprazole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 56 Reviews – Add your own review/rating
- Drug class: proton pump inhibitors
- Rabeprazole Delayed-Release Tablets
- Rabeprazole Sprinkle Capsules
- Rabeprazole (Advanced Reading)
Related treatment guides
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.